Published on September 21, 2026, a range of companies is actively developing or modifying focused ultrasound systems for veterinary applications. Research into veterinary medicine using focused ultrasound is expanding, leading to the emergence of an early device ecosystem. Some systems are specifically designed for animal patients while others adapt existing technology used in human medicine.

Read More

The development stages of these platforms vary, with many focusing on oncology, as cancer is currently a primary area of veterinary-focused ultrasound research.

Acoustiic's WaveMatrix is positioned as a versatile research platform rather than a specific veterinary product. Funded by the Focused Ultrasound Foundation in 2024, it is being adapted for companion animal use through collaboration with the Veterinary Specialty Clinic for Anesthesia and Neurology in Ottawa. This platform aims to address complex issues such as brain cancer.

Bellwether Biotech’s NanoTone is designed for a spectrum of focused ultrasound experiments, supporting both tissue studies and in vivo research. It employs programmable focused ultrasound and targeting software, with potential applications in veterinary oncology and neuromodulation. However, details on its usage in veterinary patients remain sparse.

Shenzhen PRO HITU Medical's PRO300 combines imaging and therapeutic capabilities using robotic technology initially developed for human treatment. In 2024, the company announced upgrades that expand its application to veterinary tumor treatment, demonstrating a pathway for adapting human technology for animal health.

Sinoways' SUV-II is a focused ultrasound tumor treatment robot for animals, showcasing advanced design features for veterinary workflows. This concept, which has not yet reported outcomes from veterinary testing, remains in its developmental phase.

Soundsafe Care is creating a robotic, ultrasound-guided system aimed at noninvasive thermal ablation, involving real-time imaging and automated planning. The company has initiated a precommercial program and is preparing for a clinical study on tumors in companion animals.

Researchers are also utilizing human medical systems in their veterinary studies. For example, Alpinion’s VIFU 2000, designed for small animal preclinical research, has been used for treating tumors in dogs and cats. Although now discontinued, its application in veterinary oncology is noted.

GE HealthCare's LOGIQ E10 is primarily a diagnostic tool but is undergoing investigations to explore its therapeutic potential, while Profound Medical’s Sonalleve employs MR-guided HIFU for real-time treatment monitoring in veterinary trials.

Verasonics and Sonic Concepts’ HIFUPlex PLUS aims at animal studies by integrating imaging with therapy transducers, facilitating both tissue ablation and drug delivery enhancements, as highlighted in veterinary research on liver tumors.

This information represents publicly available data as of August 2026, and does not guarantee commercial availability, regulatory approval, or clinical efficacy.